Dongguan Eontec announced that the biodegradable magnesium internal fixation screws developed by the company have successfully obtained the clinical trial summary report. This product is made of 99.99 wt.% high-purity magnesium and has advantages in biological safety, used for minimally invasive surgeries in hip preservation treatment, and can promote the growth and repair of the bone at the affected area. The clinical trial summary report indicates that this product is effective and safe in the treatment of avascular necrosis of the femoral head with vascularized bone grafting. The company will subsequently submit the product's registration application to the National Medical Products Administration. Once approved, this product will be produced and marketed, but it is currently impossible to predict its impact on the company's future Operation performance.